Endo, Auxilium And GSK Reach Deal In Testosterone MDL
Drugmakers Endo, Auxilium and GlaxoSmithKline notified an Illinois federal judge on Friday of a tentative deal to settle their cases in the testosterone replacement therapy MDL, in which thousands of patients...To view the full article, register now.
Already a subscriber? Click here to view full article